早产儿呼吸暂停药物治疗的研究现状分析

陈超; 舒先孝; 杨晓燕; 石晶; 唐军; 母得志

doi:10.7499/j.issn.1008-8830.2016.09.004

PDF(1880 KB)

HTML

中国当代儿科杂志 ›› 2016, Vol. 18 ›› Issue (9) : 806-811. DOI: 10.7499/j.issn.1008-8830.2016.09.004

论著·临床研究

早产儿呼吸暂停药物治疗的研究现状分析

陈超^1,2, 舒先孝¹, 杨晓燕^1,2, 石晶¹, 唐军¹, 母得志^1,2

作者信息 +

Current research status of drug therapy for apnea of prematurity

CHEN Chao^1,2, SHU Xian-Xiao¹, YANG Xiao-Yan^1,2, SHI Jing¹, TANG Jun¹, MU De-Zhi^1,2

Author information +

文章历史 +

摘要

目的展现近10年来国内外早产儿呼吸暂停（AOP）药物治疗的研究现状，描绘研究趋势。方法以主题词“早产儿呼吸暂停”及“治疗”在CNKI数据库、以主题词“apnea of prematurity”及“treatment”在MEDLINE数据库检索2006年1月至2015年12月的文献。筛选文献并提取关键词建立共现矩阵，使用Ucinet 6.2绘制知识图谱。结果共纳入中文关键词26个，英文关键词20个。中文关键词的共现网络图中居于核心位置的关键词为“早产儿”“呼吸暂停”“原发性呼吸暂停”“纳洛酮”和“氨茶碱”。在英文关键词的共现网络图中，居于核心位置的关键词为“apnea （呼吸暂停）”“preterm infants （早产儿）”和“caffeine （咖啡因）”。结论目前AOP的药物干预仍以甲基黄嘌呤类为主，国内主要为氨茶碱，而国外则采用咖啡因。其他药物如纳洛酮亦被应用于临床。

Abstract

Objective To investigate the current status of studies on drug therapy for apnea of prematurity (AOP) in the past decade in China and abroad, and to describe the research trends in the field. Methods CNKI and MEDLINE were searched with the key words "apnea of prematurity" and "treatment" for articles published in the past decade (January 2006 to December 2015). The articles were screened and the key words were extracted to establish the co-occurrence matrix. Ucinet 6.2 was used to plot the knowledge map. Results A total of 26 Chinese key words and 20 English key words were included. Those in the center of the co-existent knowledge map of Chinses keywords were "preterm infants", "apnea", "primary apnea", "naloxone" and "aminophylline"; while "apnea", "preterm infants" and "caffeine" located in the central place of the co-existent knowledge map of English keywords. Conclusions Methylxanthines are still the major drugs for AOP; however, aminophylline is mainly used in China, while caffeine is mainly used in foreign countries. Other drugs such as naltrexone are also used in the clinical treatment of AOP.

导出引用

陈超, 舒先孝, 杨晓燕, 石晶, 唐军, 母得志. 早产儿呼吸暂停药物治疗的研究现状分析[J]. 中国当代儿科杂志. 2016, 18(9): 806-811 https://doi.org/10.7499/j.issn.1008-8830.2016.09.004

CHEN Chao, SHU Xian-Xiao, YANG Xiao-Yan, SHI Jing, TANG Jun, MU De-Zhi. Current research status of drug therapy for apnea of prematurity[J]. Chinese Journal of Contemporary Pediatrics. 2016, 18(9): 806-811 https://doi.org/10.7499/j.issn.1008-8830.2016.09.004

参考文献

[1] Schoen K, Yu T, Stockmann C, et al. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity[J]. Paediatr Drugs, 2014, 16(2):169-177.
[2] 《中华儿科杂志》编辑委员会, 中华医学会儿科学分会新生儿学组. 早产儿管理指南[J]. 中华儿科杂志, 2006, 44(3):188-191.
[3] 叶鸿瑁. 呼吸暂停[M]//邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学. 第4版. 北京:人民卫生出版社, 2013:245-247.
[4] 钟伟金, 李佳. 共词分析法研究(一)——共词分析的过程与方式[J]. 情报杂志, 2008, 27(5):70-72.
[5] 冯璐, 冷伏海. 共词分析方法理论进展[J]. 中国图书馆学报, 2006, 32(2):88-92.
[6] 秦长江, 侯汉清. 知识图谱——信息管理与知识管理的新领域[J]. 大学图书馆学报, 2009, (1):30-37.
[7] 王宪磊. 信息管理论[M]. 北京:社会科学文献出版社, 2004:333.
[8] 储节旺, 郭春侠. EXCEL实现共词分析的方法——以国内图书情报领域知识管理研究为例[J]. 情报杂志, 2011, 30(3):45-49.
[9] Zhao J, Gonzalez F, Mu D. Apnea of prematurity:from cause to treatment[J]. Eur J Pediatr, 2011, 170(9):1097-1105.
[10] Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity[J]. N Engl J Med, 2006, 354(20):2112-2121.
[11] Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity[J]. N Engl J Med, 2007, 357(19):1893-1902.
[12] Eichenwald EC; Committee on Fetus and Newborn, American Academy of Pediatrics. Apnea of Prematurity[J]. Pediatrics, 2016, 137(1):1-7.
[13] Henderson-Smart DJ, De Paoli AG. Methylxanthine treatment for apnoea in preterm infants[J]. Cochrane Database Syst Rev, 2010, (12):CD000140.
[14] Gorodischer R, Karplus M. Pharmacokinetic aspects of caffeine in premature infants with apnoea[J]. Eur J Clin Pharmacol, 1982, 22(1):47-52.
[15] Pacifici GM. Clinical pharmacology of theophylline in preterm infants:effects, metabolism and pharmacokinetics[J]. Curr Pediatr Rev, 2014, 10(4):297-303.
[16] 陈尧, 周宏灏. 咖啡因体内代谢及其应用的研究进展[J]. 生理科学进展, 2010, 41(4):256-260.
[17] Cazeneuve C, Pons G, Rey E, et al. Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults[J]. Br J Clin Pharmacol, 1994, 37(5):405-412.
[18] 辛勤, 梁国成, 刘会臣. CYP1A2基因多态性对药物代谢的影响[J]. 国际检验医学杂志, 2013, 34(24):3378-3380.
[19] 杨晓燕, 赵静, 石晶, 等. 不同剂量氨茶碱在极低出生体重儿中的药代动力学及药效学研究[J]. 中国当代儿科杂志, 2015, 17(11):1171-1175.
[20] Yost CS. A new look at the respiratory stimulant doxapram[J]. CNS Drug Rev, 2006, 12(3-4):236-249.
[21] 黎念, 谭毅. 早产儿呼吸暂停治疗研究进展[J]. 中国临床新医学, 2014, 7(6):558-563.
[22] Henderson-Smart D1, Steer P. Doxapram treatment for apnea in preterm infants[J]. Cochrane Database Syst Rev, 2004, (4):CD000074.
[23] Prins SA, Pans SJ, van Weissenbruch MM, et al. Doxapram use for apnoea of prematurity in neonatal intensive care[J]. Int J Pediatr, 2013, 2013:251047.
[24] Roll C, Horsch S. Effect of doxapram on cerebral blood flow velocity in preterm infants[J]. Neuropediatrics, 2004, 35(2):126-129.
[25] Ten Hove CH, Vliegenthart RJ, Te Pas AB, et al. Long-term neurodevelopmental outcome after doxapram for apnea of prematurity[J]. Neonatology, 2016, 110(1):21-26.
[26] 李文斌, 常立文, 刘伟, 等. 氨茶碱联合纳洛酮防治早产儿呼吸暂停与枸橼酸咖啡因疗效比较[J]. 中华实用儿科临床杂志, 2014, 29(18):1381-1384.
[27] 黄书炜. 纳洛酮治疗早产儿呼吸暂停的临床疗效观察[J]. 广州医学院学报, 2012, 40(6):81-82.
[28] 陈敏, 张伶俐, 曾力楠, 等. 纳洛酮治疗早产儿呼吸暂停疗效和安全性的Meta分析[J]. 中国医院药学杂志, 2013, 33(24):2076-2080.
[29] MacDonald MG, Moss IR, Kefale GG, et al. Effect of naltrexone on apnea of prematurity and on plasma beta-endorphin-like immunoreactivity[J]. Dev Pharmacol Ther, 1986, 9(5):301-309.
[30] 魏端斌. 基于关键词的情报学研究主题分析[J]. 情报科学, 2006, 24(9):1400-1404.